irbesartan
Generic: irbesartan
Labeler: lupin pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
irbesartan
Generic Name
irbesartan
Labeler
lupin pharmaceuticals, inc.
Dosage Form
TABLET
Routes
Active Ingredients
irbesartan 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68180-411
Product ID
68180-411_22c8bdba-6c34-485a-af89-3aafd7fd8605
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA201531
Listing Expiration
2026-12-31
Marketing Start
2012-10-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68180411
Hyphenated Format
68180-411
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
irbesartan (source: ndc)
Generic Name
irbesartan (source: ndc)
Application Number
ANDA201531 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 16 HOW SUPPLIED/STORAGE AND HANDLING Irbesartan Tablets USP are available as white to off-white, oval shaped, uncoated tablets, debossed with a LU on one side and a code on the other (see Table below). Unit-of-use bottles contain 30 or 90 or 500 tablets as follows: 75 mg 150 mg 300 mg Debossing M11 M12 M13 Bottle of 30 68180-410-06 68180-411-06 68180-412-06 Bottle of 90 68180-410-09 68180-411-09 68180-412-09 Bottle of 500 - 68180-411-02 68180-412-02 Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Irbesartan Tablets Rx Only 75 mg NDC 68180-410-06 30's Tablets Irbesartan Tablets Rx Only 150 mg NDC 68180-411-06 30's Tablets Irbesartan Tablets Rx Only 300 mg NDC 68180-412-06 30's Tablets image 4 Image 5 Image 6
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "22c8bdba-6c34-485a-af89-3aafd7fd8605", "openfda": {"nui": ["N0000000070", "N0000175561"], "unii": ["J0E2756Z7N"], "rxcui": ["200094", "200095", "200096"], "spl_set_id": ["a7c093c2-3eef-4956-8a14-c36aada0304f"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Irbesartan", "product_id": "68180-411_22c8bdba-6c34-485a-af89-3aafd7fd8605", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]"], "product_ndc": "68180-411", "generic_name": "Irbesartan", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan", "active_ingredients": [{"name": "IRBESARTAN", "strength": "150 mg/1"}], "application_number": "ANDA201531", "marketing_category": "ANDA", "marketing_start_date": "20121023", "listing_expiration_date": "20261231"}